Pharmaceutical

Opinion: How the Wegovy shortage is making life impossi...

Medical weight management has become an endurance sport for one doctor and her p...

Randomized controlled trials are the ‘gold standard’ of...

“Maybe the larger question is, would anything be enough? For certain audiences, ...

Polio transmission was supposed to end by 2023. A new r...

In 2023 alone, there have been as many as 240 children in a couple of dozen coun...

Signal: Danaher’s $5.7bn acquisition of Abcam faces sta...

Abcam founder Jonathan Milner has declared his intention to vote against the acq...

Cure Genetics and Frametact seek gene cures for neurolo...

Cure Genetics has entered a partnership and licensing deal with Frametact to dev...

Market cap rebound by top 20 biopharmaceutical companie...

Market capitalisation increased by a total of 2.3% from $3.49tn in Q1 2023 to $3...

Generate:Biomedicines secures $273m to advance therapeu...

Generate:Biomedicines has secured $273m in Series C financing round to expedite ...

No more cookies: How healthcare companies can gain trus...

Healthcare and life sciences companies have long relied on third-party cookies f...

SparingVision shares trial updates for rare eye disease...

The company is also planning to expand its Phase I/II PRODYGY lead candidate tri...

NICE recommends Idorsia’s chronic insomnia treatment fo...

The therapy will be available to patients who have insomnia multiple times a wee...

Remote Patient Monitoring market will reach $760m by 2030

A new report found that the Remote Patient Monitoring (RPM) sector will grow, si...

Iovance’s PDUFA date for lifileucel pushed due to FDA b...

The FDA pushed lifileucel’s PDUFA date from November this year to 24 February 20...

argenx wins EMA CHMP nod for subcutaneous Vyvgart in my...

The positive opinion relied on a comparator study that showed the subcutaneous v...

Johnson & Johnson is getting rid of its script logo aft...

Johnson & Johnson will replace the well-known signature script in its logo with ...

Listen: Covid’s latest surge, Alnylam at the FDA, & the...

What does Covid-19 have in store for the winter? When are good data not good eno...

STAT+: House subcommittee forays into fixing drug short...

A House subcommittee took a first step today toward legislation to fix drug shor...